Takao Sudo

Takao Sudo

Auto-generated profile, based on publicly available information

Takao Sudo

Department of Immunology and Cell Biology, Graduate School of Medicine and Frontier Biosciences The University of Osaka Osaka Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
TSTakao Sudo
Takao Sudo
YMYasutaka Motomura
Yasutaka Motomura
DODaisuke Okuzaki
Daisuke Okuzaki
THTetsuo Hasegawa
Tetsuo Hasegawa
Takafumi YokotaTakafumi Yokota
Takafumi Yokota
MIMasaru Ishii
Masaru Ishii
The cell-cycle status of hematopoietic stem and progenitor cells (HSPCs) becomes activated following chemotherapy-induced stress, promoting bone marrow (BM) regeneration; however, the underlying molecular mechanism remains elusive. Here we show that BM-resident group 2 innate lymphoid cells (ILC2s) support the recovery of HSPCs from 5-fluorouracil (5-FU)–induced stress by secreting granulocyte-macrophage colony-stimulating factor (GM-CSF). Mechanistically, IL-33 released from chemo-sensitive B cell progenitors activates MyD88-mediated secretion of GM-CSF in ILC2, suggesting the existence of a B cell–ILC2 axis for maintaining hematopoietic homeostasis. GM-CSF knockout mice treated with 5-FU showed severe loss of myeloid lineage cells, causing lethality, which was rescued by transferring BM ILC2s from wild-type mice. Further, the adoptive transfer of ILC2s to 5-FU–treated mice accelerates hematopoietic recovery, while the reduction of ILC2s results in the opposite effect. Thus, ILC2s may function by “sensing” the damaged BM spaces and subsequently support hematopoietic recovery under stress conditions.

15 April 2022 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
TOTakayuki Ozawa
Takayuki Ozawa
KFKentaro Fujii
Kentaro Fujii
TSTakao Sudo
Takao Sudo
YDYukiko Doi
Yukiko Doi
RNRitsuko Nakai
Ritsuko Nakai
Takafumi YokotaTakafumi Yokota
Takafumi Yokota
Epigenetic mechanisms underpin the elaborate activities of essential transcription factors in lymphocyte development. Special AT-rich sequence-binding protein 1 (SATB1) is a chromatin remodeler that orchestrates the spatial and temporal actions of transcription factors. Previous studies have revealed the significance of SATB1 in T cell lineage. However, whether and how SATB1 controls B cell lineage development is yet to be clarified. In this study, we show that SATB1 is an important factor during splenic B cell maturation. By analyzing SATB1/Tomato reporter mice, we determined the dynamic fluctuation of SATB1 expression in the B cell lineage. Although SATB1 expression decreased to minimal levels during B cell differentiation in the bone marrow, it resurged markedly in naive B cells in the spleen. The expression was dramatically downregulated upon Ag-induced activation. Splenic naive B cells were subdivided into two categories, namely SATB1high and SATB1−/low, according to their SATB1 expression levels. SATB1high naive B cells were less susceptible to death and greater proliferative than were SATB1−/low cells during incubation with an anti-IgM Ab. Additionally, SATB1high cells tended to induce the expression of MHC class II, CD86, and CD83. Accordingly, naive B cells from B lineage–specific SATB1 conditional knockout mice were more susceptible to apoptosis than that in the control group upon anti-IgM Ab stimulation in vitro. Furthermore, conditional knockout mice were less capable of producing Ag-specific B cells after immunization. Collectively, our findings suggest that SATB1 expression increases in naive B cells and plays an important role in their survival and maturation. Key Points SATB1 expression increases in naive B cells and decreases upon BCR activation. SATB1 has roles in the growth and maturation of naive B cells upon BCR activation. SATB1 supports the survival of naive B cells by regulating antiapoptotic genes.

9 September 2025 in The FASEB Journal
Verified
Journal Article
Open access
EYErika Yamashita
Erika Yamashita
SHSoichiro Hashimoto
Soichiro Hashimoto
HAHiroaki Abe
Hiroaki Abe
TSTakao Sudo
Takao Sudo
DODaisuke Okuzaki
Daisuke Okuzaki
MIMasaru Ishii
Masaru Ishii
In bone marrow, cell numbers are balanced between production and loss. After chemotherapy, blood cell counts decrease initially but later recover as hematopoietic progenitor cells expand, although the mechanisms underlying this recovery are still unclear. We investigated the influence of red blood cells (RBCs) on hematopoietic stem cell (HSC) function during bone marrow recovery. Following chemotherapy, RBC concentrations in bone marrow peaked on day 5 posttreatment, coinciding with the recovery of hematopoiesis. Coculture of HSCs with RBCs resulted in a significant increase in hematopoiesis. Direct contact between RBCs and HSCs was essential for enhancement of hematopoiesis, and HSCs precultured with RBCs resulted in greater numbers of donor‐derived mature hematopoietic cells after transplantation. RNA‐sequencing analysis showed that Hes1 was the most significantly upregulated transcription factor in RBC coculture, and the response to RBC‐induced hematopoiesis of Hes1‐deficient HSCs was reduced. These findings imply a role of RBCs and Hes1 in the enhancement of hematopoietic recovery following bone marrow stress.